2[3]Felson DT, Anderson. JJ, Meenan RF. The comparative efficacy and toxicity of second - line drugs in rheumatoid arthritis. Arthritis Rheum, 1990,33: 1449.
3[4]Felson DT, Anderson JJ, Meenan RF. Use of short- term efficacy/toxicity tradeoffs to select second - line drugs in rheumatoid arthritis. Arthritis Rheum, 1992,35:1117.
4[6]Wike WS, Clough JD. Therapy for rheumatoid arthritis:combin- ations of disease - modifying drugs and paradigms of treatment. Semin Arthriti Rheum, 1991, 21(suppl 1):21.
5[7]Wilske KR, Healey LA. Remodeling the pyramid - a concept whose time has come. J Rheumatol, 1989,16:565.
